Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05953610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endotypic Traits and Obstructive Sleep Apnea Surgery

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Primary and study completion dates: Aug 31, 2027 to Aug 31, 2028v5
  3. Re-verified, no change to tracked fieldsv4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 1, 2023 to Jan 7, 2024
    • Site details revised at 2 of 2 sites
    v3
  5. Start date: Sep 1, 2023 to Dec 1, 2023
    • Study sites: 1 to 2
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine factors associated with outcomes after soft palate surgery and medications (acetazolamide, eszopiclone) that may treat other potential causes of obstructive sleep apnea (loop gain, arousal threshold).
Trial Details
NCT Number NCT05953610
Lead Sponsor University of California, Los Angeles
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Obstructive Sleep Apnea
Related terms Sleep Apnea, Obstructive
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov